AI visibility platform, research study or agency?
Choose an AI visibility platform, a research study or an agency according to the decision you need to make and who will carry out the work. Their capabilities can overlap. The useful comparison concerns evidence depth, ongoing workflow, interpretation and execution responsibility.
Compare the jobs
When choosing an AI visibility platform, research study or agency, separate the jobs before comparing suppliers. Continuous monitoring, validation of a disputed finding, interpretation for leadership and hands-on implementation can require different skills and operating arrangements. The table below describes questions to put to a provider, rather than fixed capabilities of every platform or agency. Procurement should establish who performs each job and who remains accountable for the decision.
A platform may support repeated observation, workflow and analysis. Its usefulness depends on the actual product, coverage and access to supporting evidence. A focused research commission defines a question, examines the evidence and develops supported interpretations. An agency turns a client brief into strategy, content, technical changes or communications within its mandate.
These are roles, not rigid categories. A platform can offer research services; an agency can conduct strong research; a study can use an existing monitoring system. Evaluate the actual engagement rather than assuming that every tool only counts mentions.
| Job | Platform discussion | Research discussion | Agency discussion |
|---|---|---|---|
| Ongoing monitoring | Coverage, cadence and retained evidence? | What new collection is needed? | Who uses and reviews the signals? |
| Question-specific investigation | Can the panel answer this decision? | What scope can resolve the uncertainty? | Which client uncertainty needs research? |
| Evidence validation | Can attribution and sources be inspected? | How are disputed matches resolved? | Who checks facts before implementation? |
| Business calibration | Who interprets results for the decision? | How are strengths and counter-signals retained? | How does the client validate relevance? |
| Architecture | What design support is included? | Is deeper architecture separately scoped? | How will the team use the design? |
| Implementation | Which actions are actually provided? | What is the research handoff? | Who writes, builds and operates? |
The organizational pathway describes the diagnosis a client can commission; the agency pathway explains how that contribution fits an adviser’s relationship and execution role.
Know when each is useful
Consider this illustrative procurement choice: a team already has a usable record of changing mentions, but cannot tell whether a competitor is a provider or a cited publisher. More observation alone may leave that uncertainty unresolved. Commission entity and source-role validation first. If the distinction is already clear and the team has approved a correction, fund execution rather than another general review.
If the question is “What changed in our tracked panel?”, an existing tool may already provide enough evidence. If the question is “Does this difference concern the right entity, and does it justify changing our positioning?”, additional investigation and business calibration may be needed.
If the diagnosis is understood but implementation is missing, another report may not be the best next investment. Clarify the execution task and appoint the team with the relevant skills.
Before adding a subscription or commission, identify the person who will use the evidence. A board-level concern may need a concise explanation of materiality and uncertainty; a digital team may need a maintained observation workflow; an agency may need a specific source and content brief. Choose the output and review rhythm for that user. A supplier's attractive interface is useful only if the team can connect it to the decision and inspect the supporting evidence when necessary.
Evaluate an actual provider
When choosing an AI visibility platform, research study or agency, ask how a provider handles company aliases, subsidiaries, competitors and source attribution. Request an explanation of the observations behind a commercially important conclusion, including unresolved matches and contrary answers. Check whether website, publisher and social evidence are within the proposed scope. A broad coverage claim is less useful than a clear account of what can actually be inspected.
Ask to inspect how a representative finding was produced. Check the question set, systems and surfaces, entity matching, sources, denominator, exclusions and access rights. Ask how uncertainty and contradictory evidence are handled. Named product features require current vendor documentation; this guide does not rank products or claim a universal winner.
Use the study-evaluation guide to test an actual provider’s evidence and claims before deciding which role it should fulfil.
Before comparing scores, inspect their populations using measurement and uncertainty. If verification requires private evidence, access and reuse identifies the permissions that must accompany it.
Combine the work coherently
When choosing an AI visibility platform, research study or agency, a combined scope should avoid paying twice for the same collection work. AAI Kernel can assess whether existing evidence is fit for a focused diagnosis and what additional research is required. The executive sponsor approves the questions and priorities, the research contributor explains the basis, and the agency translates an approved brief into work. Agree evidence transfer and permitted reuse before relying on another provider's dataset.
Agree who collects observations, who validates them, who makes strategic decisions and who implements changes. Define the handoff, permitted reuse and follow-up before work begins. AAI Kernel can discuss a focused investigation alongside the tools and agencies you already use.
The commissioning guide turns that division of work into an agreed question, evidence scope and handoff, so a new commission has a distinct purpose.
When the missing contribution is clear, describe it through Contact with the work already available and the decision it has not resolved.
Common questions
- Can we commission research alongside Profound or Scrunch?
- Yes. A focused study can be scoped alongside an existing platform where the evidence access and responsibilities are clear. No particular vendor feature is assumed here.
- Is AAI Kernel a monitoring subscription or an implementation agency?
- AAI Kernel's offer centers on research, diagnosis and separately scoped architecture. Your team or agency implements the agreed response.
Discuss research alongside your current tools
Tell us what your existing platform or agency already answers and which decision remains unresolved. We can assess where focused research would add value.
07 Where this leads
The division of work matters most at the handoff. The agency-brief example shows what research must explain so an agency can challenge a priority and plan execution. It makes the choice concrete: which evidence is already available, which uncertainty remains, and who will act on the answer?